{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-038888","form_type":"8-K","ticker":"HRMY","cik":"0001802665","company_name":"Harmony Biosciences Holdings, Inc.","filed_at":"2026-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.934207+00:00","generated_at":"2026-05-15T07:51:58.639781+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Harmony Biosciences appoints Peter Anastasiou as COO; adds Troy Ignelzi to Board","bullets":["Peter Anastasiou named SEVP and COO, effective April 2, 2026; resigns from Board.","Troy Ignelzi appointed Class III director, filling vacancy; will serve on Audit and Compensation Committees.","Antonio Gracias will not stand for re-election at 2026 annual meeting; term ends May 14, 2026.","Geno J. Germano nominated for election to Board at 2026 annual meeting.","Anastasiou receives $600K base salary, 55% bonus target, $3.7M option award with 4-year vest."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-038888","json":"https://secwatch.observer/filing/0001104659-26-038888.json","markdown":"https://secwatch.observer/filing/0001104659-26-038888.md","text":"https://secwatch.observer/filing/0001104659-26-038888.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802665/000110465926038888/0001104659-26-038888-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802665/000110465926038888/hrmy-20260331x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:51:58.639781+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}